Healthcare and Research Infrastructure
Claim Your Profile to Add Information
Description
Latvia has emerged as a high-growth hub within the European life sciences ecosystem, distinguished by expertise in pharmaceutical manufacturing and cutting-edge biotechnology research.
The nation is a premier destination for biopharma investment, anchored by industry giants that dominate the regional market in drug development and high-value exports.
At the heart of its healthcare innovation is a robust precision medicine framework, bolstered by the 2026 merger of the Latvian Institute of Organic Synthesis (LIOS) and the Latvian Biomedical Research and Study Centre into a singular National Research powerhouse.
In the medical device sector, Latvia excels in optical fiber technologies and medtech startups.
The country’s academic research excellence is driven by Riga Stradiņš University, a leader in oncology, immunology and molecular biology.
With a focus on sustainable chemistry and biotech innovation, the Latvian life sciences cluster offers a strategic gateway to EU markets.
Global partners benefit from a highly skilled workforce, world-class R&D infrastructure and a competitive bio-economy focused on the future of personalized medicine.
Featured Editorial
Government and Public Research Funding
Claim Your Profile to Add Information
Investment and Financing
Claim Your Profile to Add Information
Industry Presence
Claim Your Profile to Add Information
Big Medtech Presence
Claim Your Profile to Add Information
Active Clinical Studies
Claim Your Profile to Add Information
